Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog

World Hepatitis Day 2021

Posted on July 15th, 2021 by

Pharma R&D

Every 30 seconds, a person dies from a hepatitis-related illness. This terrible death toll is why the mantra for World Hepatitis Day (July 28) this year is “Hepatitis Can’t Wait”.

(more…)

How the Elsevier Foundation partnerships support sustainable development

Posted on July 7th, 2021 by

Chemistry

OWSD-Elsevier Foundation Awards for Early-Career Women Scientists in the Developing World award winners

Each year, the Elsevier Foundation gives over $1 million to an array of non-profit organizations. This support has gone to promising collaborations, STEM initiatives, leadership programs, technology platforms, early to mid-career scholars and more.

(more…)

Collecting DNA from thin air

Posted on July 2nd, 2021 by

Pharma R&D

In a proof-of-concept study published this spring, researchers revealed that animal DNA can be collected from air sampling. The study’s authors have dubbed this DNA “airDNA,” and it could open up a lot of possibilities for better understanding the world around us.

(more…)

Confronting the Problem of AI Bias

Posted on June 18th, 2021 by

AI & Data

When thinking of artificial intelligence (AI), many people rely on cultural touchstones from science fiction films and TV. They might think of HAL, the calm-voiced AI from 2001: A Space Odyssey, or Data, the even-tempered android from Star Trek. We tend to imagine that artificial intelligence will be driven by reason, logic and facts – not by the emotions and prejudices that get us regular humans into trouble so often.

(more…)

An Update on Global Availability of COVID-19 Vaccines from Editor of The Lancet

Posted on June 11th, 2021 by

Pharma R&D

In the U.S., the COVID-19 vaccine roll-out has moved at a strong pace, with about half of Americans now having received at least one shot. While many of the most motivated people have been able to get vaccinated by now, plenty of others still have questions. They may wonder if the vaccines are safe in general, or safe for them personally if they have a particular condition. They may have been confronted with conflicting information about the efficacy of vaccines.

(more…)

4 Notable Life Sciences Trends from the Tech Trends Report

Posted on June 4th, 2021 by

AI & Data

The Future Today Institute has released its 2021 Tech Trends Report (14th Annual Edition), a comprehensive report on strategic trends that it anticipates will affect business, government, education, media and society in the coming year. We noted four trends discussed in the report’s Health, Medicine & Science section that will be of particular interest to those in the pharmaceutical and life sciences sectors.

(more…)

  1. 1
  2. 2
  3. 3
  4. 85

About this Blog

iStock_000019748868_Full

The Elsevier Pharma R&D blog provides insight and opinion on topics related to pharmaceutical research and development, namely: big data, target identification, new drug discovery, drug safety monitoring, risk mitigation and regulatory compliance. We serve the community of chemists, scientists, drug safety specialists, educators and students interested in pharmaceutical R&D.

Editor’s note: The views and opinions expressed are those of the author and do not necessarily reflect the views of Elsevier,  its affiliates and sponsors or its parent company, Reed Elsevier.